Ignite Creation Date:
2024-05-05 @ 5:08 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00392834
Status:
COMPLETED
Last Update Posted:
2018-06-06
First Post:
2006-10-25
Brief Title:
Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed HIV-Associated Burkitts Lymphoma
Sponsor:
AIDS Malignancy Consortium
Organization:
AIDS Malignancy Consortium
Organization Data
Organization:
AIDS Malignancy Consortium
Class:
NETWORK
Study ID:
AMC-048
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AIDS Malignancy Consortium
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| The Emmes Company LLC | INDUSTRY |
| National Cancer Institute NCI | NIH |